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Abstract 
Background: Several genome-wide association studies of primary biliary cirrhosis (PBC) in European and Japanese 
origins have shown significant association of dozens of genetic loci contributive to the susceptibility of PBC. Most of 
the loci were related to immune response pathway. In this study, we tested whether the lipid metabolic gene HELZ2 
was associated with the pathogenesis of PBC.
Methods: In 586 PBC cases (358 in case 1 group and 201 in case 2 group) and 726 healthy controls of Chinese Han, 
six nonsynonymous SNPs were genotyped by MassArray iPLEX. The same control were used for the two groups of PBC 
cases. Allele frequencies were calculated by χ2 test based on 2 × 2 contingency tables. All data were analyzed using 
the PLINK tool set. The odds ratio (OR) and 95 % confidence interval (95 % CI) were calculated, and p values (corrected 
for multiple testing by Bonferroni adjustment) less than 0.05 were considered statistically significant.
Results: The A allele of rs79267778 was significantly associated with PBC (ORcombined = 4.204 [1.670–10.582], pcom-
bined = 1.87E−04). It changed the amino acid at position 1904 (NM_001037335) from Threonine (ACG) to Methionine 
(ATG). This site was highly conserved in mammals and predicted to be POSSIBLY DAMAGING with a score of 0.469 
by PolyPhen-2. It’s further predicted that T1904 M could INCREASE the protein stability with a confidence at 25.18 % 
under the condition of pH 7.0 and 37 °C.
Conclusion: The result was the first time to show evidence of the lipid metabolic gene HELZ2 related to autoim-
mune disease, at least in PBC of Chinese Han.
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Background
Primary biliary cirrhosis (PBC) is a common autoim-
mune liver disease, characteristically associated with 
anti-mitochondrial antibodies and affecting up to 1 in 
1000 women over 40  years of age [1]. Though GWAS 
studies have found dozens of gene associated with PBC in 
European and Japanese populations. The genetic factors 
contributing to the pathogenesis still remain elusive.
HELZ2 [OMIM 611265], also known as PRIC285 or 
PDIP1, is a 2649 amino acid nuclear helicase protein, 
being a part of the peroxisome proliferator activated 
receptor α interacting (PRIC) complex [2]. It func-
tions as a nuclear transcriptional coactivator for PPARA 
and PPARG, as well as other nuclear receptors (RXRA, 
THRA, THRB) [2, 3]. Inferred from items of gene ontol-
ogy, this gene is mainly related with cellular lipid meta-
bolic process [4] and liver regeneration [5].
It had been reported that HELZ2’s binding partner, 
Pparg could regulate the expression of inflammatory genes 
such as Ccl3, Ccl7, Cxcl10 and Tgtp in mice [6]. This gene 
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also played an important role in innate immune responses 
[7] and related to immune-related diseases, such as HCV/
HIV infection [8], osteoarthritis [9], acne vulgaris [10]. 
As to itself, HELZ2 possessed the ability to bind proteins 
important for immune responses, such as BCL6 [11] and 
ISG15 [12]. Therefore, we inferred that HELZ2 might be 
associated with autoimmune diseases. Since it could affect 
liver regeneration, this gene had the promising potentiality 
to contribute to the pathogenesis of PBC.
In order to verify the assumption, we selected 6 non-
synonymous SNPs in the coding region of HELZ2 from 
1000 Genomes Project for Asian populations with 
MAF  >2  % and genotyped in 586 PBC cases and 726 
healthy controls with Chinese Han. Of the 6 SNPs, the 
T allele of rs79267778 was found to significantly asso-
ciated with PBC (ORcombined  =  4.204 [1.670−10.582], 
pcombined = 1.87E−04). It changed the amino acid at posi-
tion 1904 (NM_001037335) from Threonine (ACG) to 
Methionine (ATG). Conservation analysis showed this site 
was highly conserved in mammals and might influence 
the function of HELZ2. The result was the first time to 
show evidence of the lipid metabolic gene HELZ2 related 
to autoimmune disease, at least in PBC of Chinese Han.
Methods
Information of the recruited subjects
The peripheral blood mononuclear cells (PBMCs) of 
a total of 385 PBC subjects (case 1 group) and 726 age-
matched healthy controls were collected by the Rheu-
matology Department of Peking Union Medical College 
Hospital and 201 PBC samples (case 2 group) collected 
from multiple medical centers in China (Table  1). The 
healthy control were used for the two groups of cases. 
All patients fulfilled the criteria of the American Asso-
ciation for the Study of Liver Diseases for primary biliary 
cirrhosis [13]. All patients and controls were unrelated 
individuals of Han Chinese ethnicity by self-report. 
The study was approved by the ethics committee of the 
Peking Union Medical College hospital and all subjects 
gave informed consent.
Genotyping of selected SNPs in HELZ2
The genomic DNA of each sample was extracted using 
QIAamp DNA mini kit (Qiagen, German), and SNP 
genotyping was performed by the MassArray iPLEX sys-
tem (Sequenom, USA) at Beijing DnaLead Co. LTD. All 
procedures were performed according to the manufactur-
er’s instructions. Approximately 10 ng of genomic DNA 
was amplified by multiplex PCR and the amplicons sub-
jected to locus-specific single-base extension reactions. 
The extended products were desalted and transferred to 
a 384-element SpectroCHIP array. Allele detection was 
performed using MALDI-TOF mass spectrometry, and 
the mass spectrograms were analyzed by the MassArray 
TYPER software v4.0 (Sequenom, USA). 6 SNPs in the 
coding sequence of HELZ2 were selected for genotyping 
in the 2 cohorts of Chinese Han (385 cases/726 controls 
and 201 cases/726 controls) by MassArray iPLEX.
Association analysis of the genotyped SNPs
The genotyped SNPs were tested for Hardy–Weinberg 
equilibrium (HWE) in the patient and control popula-
tions, and any SNPs that deviated from HWE (p < 0.05 
in the control group) were excluded from subsequent 
analyses. Allele frequencies were calculated by χ2 test 
based on 2 × 2 contingency tables. Since the incidence 
of PBC was both gender and age related, we took gender 
and age as covariates in our analysis. All data were ana-
lyzed using the PLINK tool set. The odds ratio (OR) and 
95 % confidence interval (95 % CI) were calculated, and 
p values (corrected for multiple testing by Bonferroni 
adjustment) less than 0.05 were considered statistically 
significant.
Results
Structural survey of the genomic region with HELZ2
We extracted structural variation data of the region 
(chr20:62,089,439-62,305,592) from the Database of 
Genomic Variants [14] and mapped against human refer-
ence genome (hg19). HELZ2 was encircled by common 
deletion polymorphisms. Besides, HELZ2 was located in 
a region with high recombination rate (cM/Mb) (Fig.  1, 
upper panel). The LD pattern showed that HELZ2 was 
in a weakly linked block (Fig.  1 lower panel). Based on 
these preliminary information, 6 nonsynonymous SNPs 
in the coding region of HELZ2 were selected from 1000 
Genomes Project for Asian populations with MAF >2 % 
for further genotyping (Table 2).
Table 1 Samples information
Groups Total Genders Ages
Female Male Minimum Maximum Mean ± SD
Case 1 385 358 27 16 75 34.69 ± 12.61
Case 2 201 185 16 18 80 35.53 ± 9.87
Control 726 680 46 11 79 34.20 ± 11.25
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Association of rs79267778 (T1904 M) with PBC in Chinese 
Han
Of the 6 nonsynonymous SNPs, five were successfully 
genotyped and one (rs114867526) failed. After analysis, 
only one SNP, rs79267778, was found to be significantly 
associated with PBC in the first cohort of PBC samples 
(358 cases/726 controls) (p  =  3.62E−03). In order to 
validate the associatioin, 201 PBC samples from multi-
ple medical centers were genotyped and compared with 
same control samples, rs79267778 was also marginally 
associated with the disease (p = 2.07E−02). After com-
bination analysis, the SNP was strongerly linked with the 
pathognesis of PBC (ORcombined =  4.204 [1.670–10.582], 
pcombined  =  1.87E−04) (Table  2). rs79267778 located in 
the largest exon (E9) of HELZ2 (Fig.  2a). The risk allele 
(A allele) changed the amino acid at position 1904 
(NP_001032412) from Threonine (ACG) to Methionine 
(ATG).
T1904 M was highly conserved in mammals
Sequences around rs79267778 of 14 species were extract 
and aligned by the molecular evolutionary genetics anal-
ysis software, MEGA v4.0 [15]. The first (A) and second 
(C) nucleotide of the codon for Threonine (ACG) was 
highly conserved, with the third varied greatly (Fig. 2b). 
This mutation was predicted to be POSSIBLY DAMAG-
ING with a score of 0.469 by PolyPhen-2. The web-based 
software, MuStab (Predicting Mutant Protein Stability 
Change) was applied to predict if the SNP could influ-
ence the stability of HELZ2. Under the condition of pH 
7.0 and 37  °C, T1904  M could INCREASE the protein 
stability with a confidence at 25.18 %.
Fig. 1 Linkage disequilibrium of the region containing HELZ2. Upper panel showed the recombination rate (cM/Mb) (hg19, estimated using all 
populations of HapMap Phase 2: CEU Utah residents of Northern and Western European ancestry, JPT Japanese in Tokyo, Japan, CHB Han Chinese in 
Beijing, China, YRI Yoruba in Ibadan, Nigeria. Genetic recombination rates were represented by grey line, and genes within the region were shown in 
the middle panel. The lower panel showed the pairwise linkage disequilibrium between SNPs in this region. The color of each diamond represented 
the pairwise linkage between SNPs (measured as r2) defined by the upper left and the upper right sides of the diamond. Shading represented the 
magnitude of pairwise LD, with a red-to-white gradient reflecting higher to lower LD values
Table 2 Association of SNPs with primary biliary cirrhosis in Chinese Han
a Two groups of PBC cases
b The same control group




Case 1a Controlb p value Case 2a Controlb p value
rs3810481 G 0.407 0.462 0.054 0.434 0.462 0.086 0.801 [0.647–0.991] 0.044
rs3810483 G 0.125 0.170 0.210 0.154 0.170 0.340 0.822 [0.599–1.127] 0.23
rs79267778 T 0.024 0.006 3.62E−03 0.019 0.006 2.07E−02 4.204 [1.670–10.582] 1.87E−04
rs3810486 A 0.393 0.418 0.174 0.405 0.418 0.333 0.820 [1.416–2.347] 0.3107
rs6089924 A 0.004 0.011 0.057 0.009 0.011 0.405 0.377 [0.100–1.426] 0.2248
rs114867526 A – – – – – – – –
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Discussion
Previous GWAS had identified dozens of loci suscepti-
ble to primary biliary cirrhosis in European and Japa-
nese population, such as HLA-DQB1, IL12A, IL12RB2, 
STAT4, SPIB, IRF5, IKZF3, IL7R, CD80, TNFSF15 and so 
on [16–19]. The majority of these genes participated in 
immune responses. Recently, the pivotal gene for energy 
metabolism, PPARG, has been linked with some kinds of 
immune-related diseases, such as HCV/HIV infection, 
osteoarthritis and acne vulgaris. As the important coac-
tivator for PPARG, HELZ2 could bind proteins important 
for immune responses, such as BCL6 and ISG15. There-
fore, we speculated that HELZ2 might be associated with 
autoimmune diseases. Since it could affect liver regenera-
tion, HELZ2 had the highly potentiality to contribute to 
the pathogenesis of primary biliary cirrhosis.
Using a panel of 6 nonsynonymous SNPs of HELZ2 
selected for association in 2 cohorts of Chinese Han, 
our results showed significant association of a rare 
SNP, rs79267778 with PBC in Han Chinese (ORcombined   
= 4.204 [1.670−10.582], pcombined = 1.87E−04).
Recently, Fairfax B. reported that a known autoim-
mune disease locus, rs11171739 at 12q13.2 could trans-
regulate the expression of PRIC285 (a well-known name 
for HELZ2) in B cells and suggested peroxisome prolif-
erator-activated receptor γ (PPARG) signaling might be 
involved in autoimmune pathogenesis [20]. In this study, 
a nonsynonymous SNP in the coding region of HELZ2 
was identified to significantly associated with PBC.This 
was the first genetic analysis to associate HELZ2 with the 
pathogenesis of autoimmune disease, at least for primary 
biliary cirrhosis in Han Chinese. Except for PBC, there 
are at lease 2 types of other autoimmune-related liver dis-
eases, such as autoimmune hepatitis (AIH) and primary 
sclerosing cholangitis (PSC). The relationship of HELZ2 
with AIH and PSC should be elucidated further.
Since rs79267778 could change the coding of amino 
acid at position 1904 of HELZ2, we inferred that it might 
affect the structure of DNA binding domain or transcrip-
tion factor binding domain of the protein. According to 
the conserved domains of HELZ2, it contains 7 domains, 
AAA domain (519–590), DNA2 domain (642–938), 
UvrD_C_2 domain (713–915), P-loop_NTPase domain 
(2150–2189), AAA_11 domain (2152–2399), AAA_12 
domain (2406–2611). T1904  M does not locate in any 
functional domains of the protein. The stability change of 
HELZ2 was predicted using MuStab for T1904 M. inter-
estingly, the SNP could INCREASE the protein stability 
with a confidence at 25.18 %. The stabilized HELZ2 could 
prolong the half-life of its ligand-dependent nuclear 
receptor transcription coactivator activity. However, pre-
cise molecular mechanism of the variant of HELZ2 with 
primary biliary cirrhosis should be elucidated further.
Conclusion
This was the first evidence to show that the lipid metab-
olism-related gene, HELZ2 was linked with autoimmune 
disease, at least for primary biliary cirrhosis in Chinese 
Han population. Further studies should be performed to 
reveal the impact of this SNP on the function of HELZ2.
Authors’ contributions
GL and YL conceived the project. GL designed the assays and experiments. 
PL and GL performed the experiments. PL, ZW, SC, JL, SL, YC and JL collected 
the samples and extracted genomic DNAs. GL wrote the paper. YL and GL 
supervised the procedure of this project and revised the manuscript. FZ and 
Fig. 2 Diagram of HELZ2 and conservation of rs79267778. a The structure of HELZ2 gene. Green and red boxes represented 5′ UTR and 3′ UTR, 
respectively. Blue box indicated exons, thin line between boxes represented introns, red line indicated the location of rs114867526. Arrow indicated 
the direction of transcription. b The alignment of sequences around rs79267778 from 14 species
Page 5 of 5Li et al. Allergy Asthma Clin Immunol  (2016) 12:14 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
SM provided valuable discussion. GL, PL and LW contributed equally to the 
work. All authors read and approved the final manuscript.
Author details
1 Key Laboratory of Rheumatology and Clinical Immunology, Department 
of Rheumatology and Clinical Immunology, Peking Union Medical College 
Hospital, Peking Union Medical College and Chinese Academy of Medical 
Sciences, Ministry of Education, Beijing, China. 2 Department of Blood Transfu-
sion, Tangdu Hospital, The Fourth Military Medical University, Xi’an, China. 
Acknowledgements
We thank all participants recruited in this study. This work was supported by 
grants from the National Natural Science Foundation of China (81101490 to G. 
Lu, 81373188 to Y. Li, and 81172857 to Y. Li), Research Special Fund for Public 
Welfare Industry of Health (201202004 to Y. Li), the Chinese National High 
Technology Research and Development Program, Ministry of Science and 
Technology Grants (2011AA02A113 to Y. Li) and the National Science Technol-
ogy Pillar Program in the 12nd Five-year Plan (2014BAI07B00 to Y. Li).
Competing interests
The authors declare that they no competing interests.
Received: 23 October 2015   Accepted: 17 February 2016
References
 1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. New Engl J Med. 
2005;353(12):1261–73.
 2. Surapureddi S, Yu S, Bu H, Hashimoto T, Yeldandi AV, Kashireddy P, Cherka-
oui-Malki M, Qi C, Zhu YJ, Rao MS, et al. Identification of a transcriptionally 
active peroxisome proliferator-activated receptor alpha-interacting cofac-
tor complex in rat liver and characterization of PRIC285 as a coactivator. 
Proc Natl Acad Sci USA. 2002;99(18):11836–41.
 3. Tomaru T, Satoh T, Yoshino S, Ishizuka T, Hashimoto K, Monden T, Yamada 
M, Mori M. Isolation and characterization of a transcriptional cofactor and 
its novel isoform that bind the deoxyribonucleic acid-binding domain 
of peroxisome proliferator-activated receptor-gamma. Endocrinology. 
2006;147(1):377–88.
 4. Katano-Toki A, Satoh T, Tomaru T, Yoshino S, Ishizuka T, Ishii S, Ozawa 
A, Shibusawa N, Tsuchiya T, Saito T, et al. THRAP3 interacts with HELZ2 
and plays a novel role in adipocyte differentiation. Mol Endocrinol. 
2013;27(5):769–80.
 5. Viswakarma N, Matsumoto K, Jia Y, Rao MS, Reddy JK. Mice lacking tran-
scription cofactor PRIC285 reveal attenuation of liver regeneration but 
are viable and develop normally. FASEB J. 2009;23:117.
 6. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson 
TM, Rosenfeld MG, Glass CK. A SUMOylation-dependent pathway medi-
ates transrepression of inflammatory response genes by PPAR-gamma. 
Nature. 2005;437(7059):759–63.
 7. Berruyer C, Pouyet L, Millet V, Martin FM, LeGoffic A, Canonici A, Garcia 
S, Bagnis C, Naquet P, Galland F. Vanin-1 licenses inflammatory mediator 
production by gut epithelial cells and controls colitis by antagonizing 
peroxisome proliferator-activated receptor gamma activity. J Exp Med. 
2006;203(13):2817–27.
 8. Fernandez-Rodriguez A, Berenguer J, Rallon N, Jimenez-Sousa MA, Lopez 
JC, Soriano V, Garcia-Alvarez M, Cosin J, Martinez P, Guzman-Fulgencio M, 
et al. PPARgamma2 Pro12Ala polymorphism is associated with sustained 
virological response in HIV/HCV-coinfected patients under HCV therapy. J 
Acquir Immune Defic Syndr. 2014;67(2):113–9.
 9. Zhang B, Xie QG, Quan Y, Pan XM. Expression profiling based on graph-
clustering approach to determine osteoarthritis related pathway. Eur Rev 
Med Pharmacol Sci. 2013;17(15):2097–102.
 10. Amr K, Abdel-Hameed M, Sayed K, Nour-Edin F, Abdel Hay R. The 
Pro12Ala polymorphism of the gene for peroxisome proliferator activated 
receptor-gamma is associated with a lower Global Acne Grading System 
score in patients with acne vulgaris. Clin Exp Dermatol. 2014;39(6):741–5.
 11. Miles RR, Crockett DK, Lim MS, Elenitoba-Johnson KS. Analysis of BCL6-
interacting proteins by tandem mass spectrometry. Mol Cell Proteom. 
2005;4(12):1898–909.
 12. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 
conjugation targets both IFN-induced and constitutively expressed 
proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA. 
2005;102(29):10200–5.
 13. Heathcote EJ. Management of primary biliary cirrhosis. The American 
Association for the Study of Liver Diseases practice guidelines. Hepatol-
ogy. 2000;31(4):1005–13.
 14. MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW. The database 
of genomic variants: a curated collection of structural variation in the 
human genome. Nucl Acid Res. 2014;42:D986–92.
 15. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular evolution-
ary genetics analysis (MEGA) software version 4.0. Mol Biol Evol. 
2007;24(8):1596–9.
 16. Nakamura M, Nishida N, Kawashima M, Aiba Y, Tanaka A, Yasunami M, 
Nakamura H, Komori A, Nakamuta M, Zeniya M, et al. Genome-wide 
association study identifies TNFSF15 and POU2AF1 as susceptibility loci 
for primary biliary cirrhosis in the Japanese population. Am J Hum Genet. 
2012;91(4):721–8.
 17. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, Shin SY, Heneghan 
MA, Neuberger JM, Donaldson PT, Day DB, et al. Genome-wide associa-
tion study identifies 12 new susceptibility loci for primary biliary cirrhosis. 
Nat Genet. 2011;43(4):329–32.
 18. Liu X, Invernizzi P, Lu Y, Kosoy R, Lu Y, Bianchi I, Podda M, Xu C, Xie G, Mac-
ciardi F, et al. Genome-wide meta-analyses identify three loci associated 
with primary biliary cirrhosis. Nat Genet. 2010;42(8):658–60.
 19. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran 
BD, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 
variants. New Engl J Med. 2009;360(24):2544–55.
 20. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A, Ellis 
P, Langford C, Vannberg FO, Knight JC. Genetics of gene expression in 
primary immune cells identifies cell type-specific master regulators and 
roles of HLA alleles. Nat Genet. 2012;44(5):502–10.
